scorecardresearch
Wednesday, August 27, 2025
TopicJohnson and Johnson

Topic: Johnson and Johnson

Johnson & Johnson stops selling baby powder in US, Canada after multiple lawsuits

The healthcare giant has faced lawsuits accusing it of hiding the cancer risks tied its talc-based version of baby powder since 2014.

Study finds baby powder not likely a risk for ovarian cancer

The US-govt-sponsored study may help Johnson & Johnson's fight against 17,000 lawsuits contending that talc-based personal hygiene products cause ovarian cancer in women.

J&J says no asbestos found in baby powder, disputing FDA test

The company suggested that contamination of a lab, which it recreated in several of its own third-party tests, could have caused the FDA’s positive result.

India to re-test Johnson & Johnson baby powder samples, after firm recalls batch in US

Last week, US Food and Drug Administration issued an alert that a particular lot of J&J’s baby powder had tested positive for asbestos — a carcinogen.

Johnson & Johnson recalls baby powder batch in US after tests find cancer-causing asbestos

J&J has been under scanner for long, but this is the first time FDA has announced a finding of asbestos. Recent lab tests in India had found the product fit.

Govt says J&J baby shampoo safe, months after it was flagged for cancer-causing substance

The Rajasthan FDA in March had claimed that two batches of J&J baby shampoo were found contaminated with formaldehyde, a carcinogen.

Johnson & Johnson directed to pay Rs 25 lakh each to 67 patients for faulty hip implants

The Delhi High Court said it hadn't examined the controversy so this payment won't limit patients from seeking further compensation.

Boeing’s 737 Max defence is a textbook mess

With Boeing not having informed pilots about the new automated feature, its main defence in the 2 crashes that killed 346 people boils down to quibbling about the meaning of the term safety feature.

After J&J implant row, govt plans to hire 750 officers to regulate medical devices

Plan is to hire these officers, who will exclusively regulate sale of medical devices such as coronary stents & hip implants, through a written exam conducted by UPSC.

Delhi HC junks Johnson & Johnson plea for stay on Rs 74 lakh payout for faulty hip implant

The Delhi High Court order on Johnson & Johnson's stay plea comes days before the Centre's deadline for the payout — 10 April — expires.

On Camera

India will absorb Trump tariff impact due to its Achilles’ heel

Like China, India remains a big domestic market, which will continue to attract investment, but the US tariffs will make India unattractive for future investments.

New insolvency frameworks to shorter timelines, how 2025 amendment bill proposes to transform IBC

New bill aims to fix key issues with IBC 2016, including delays & patchy implementation, and protect creditors, with window for genuine promoters to retain control of their companies.

Op Sindoor lesson: IAF chief bats for joint planning & coordination centre in Delhi, not theaterisation

Contrary to claims regarding implementation of theaterisation, ThePrint first reported on 17 June 2021 that it will be delayed. Now, ACM Singh bats for different structure.

That Oval Office picture for ages deserves closer Indian reading, with a geopolitical lens

Putin sees this as a victory. Europeans have decided to deal with Trump on his terms for the sake of the larger Western alliance. We look at the lessons for us in India.